MRNX - Daily Target 2X Long MRNA ETF
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options.
As of Sep 30, 2026: spot at $137.36, ATM IV 153.4%, max pain $88.00, net GEX $18.9K.
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Market Cap
- $5.9M
- Beta
- -1.97
- 52-Week Range
- 14.95-165
- IPO Date
- Feb 4, 2026
- Exchange
- AMEX
What MRNX Looks Like to Options Traders Today
positive net gamma exposure ($18.9K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.038) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The MRNX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked MRNX overview questions
- What is MRNX?
- MRNX is the ticker symbol for Daily Target 2X Long MRNA ETF, an listed exchange-traded fund. The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). Listed on AMEX. MRNX is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the MRNX options snapshot look like today?
- As of Sep 30, 2026, the MRNX options snapshot shows spot at $137.36, ATM IV 153.4%, max pain $88.00, net GEX $18.9K, expected move 43.98%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are MRNX's key statistics?
- Daily Target 2X Long MRNA ETF (MRNX) carries a market capitalization of $5.9M, 52-week range of 14.95-165. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does MRNX belong to?
- Daily Target 2X Long MRNA ETF operates in the Financial Services sector, in the Asset Management - Leveraged industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare MRNX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the MRNX data on this page?
- The options snapshot above is dated Sep 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.